Learn More
Medchemexpress LLC LCKLSL hydrochloride | 533902-29-3 | 98.05% | 712.34 | 25 MG

Supplier: Medchemexpress LLC 25MGHYP2333A
LCKLSL hydrochloride is a N-terminal hexapeptide and a competitive annexin A2 (AnxA2) inhibitor. It potently inhibits the binding of tissue plasminogen activator (tPA) to AnxA2. Additionally, this peptide has anti-angiogenic roles and inhibits the generation of plasmin.
- N-terminal hexapeptide
- Acts as a competitive annexin A2 (AnxA2) inhibitor
- Potently inhibits the binding of tissue plasminogen activator (tPA) to AnxA2
- Inhibits the generation of plasmin
- Exhibits anti-angiogenic properties
- Suppresses VEGF-induced tPA activity under hypoxic conditions
- Decreases vascular length in angiogenesis models
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.